Vigil Neuroscience (VIGL)
(Delayed Data from NSDQ)
$4.40 USD
+0.21 (5.01%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $4.26 -0.14 (-3.18%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Brokerage Reports
Vigil Neuroscience, Inc. [VIGL]
Reports for Purchase
Showing records 21 - 40 ( 46 total )
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
IGNITE Interim Data Might Set the Tone for VGL101; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Natural History Data and Biomarkers Are Guiding Force for IGNITE; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Execution in Bloom As VIGL Advances Pipeline Efforts [1Q23 Highlights]
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Notes From The (Virtual) Road... Execution On Display As VGL101 Advances
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Nothing Holding Them Back - FDA Lifts Partial Clinical Hold
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Regulatory Environment Encouraging For VGL101; Reit Buy and PT $24
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
MRI and NfL Might Illuminate IGNITE-Takeaways From Vigil?s KOL Event; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
ALSP KOL Event Takeaways: 2023 Marks An Important Year For VIGL
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Natural History Data Important for Rare Diseases like ALSP; Reit. Buy and $24 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Reiterate Outperform Rating - Continue to See Differentiation With VGL101
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Reiterate Outperform Rating - Continue to See Differentiation With VGL101
Provider: Wedbush Securities Inc.
Analyst: CHICO L